Table 1. Patient characteristics.
A | B | Total | C | D | Total | |
---|---|---|---|---|---|---|
No. of eligible patients | 87 | 85 | 172 | 48 | 47 | 95 |
Sex | ||||||
Male | 49 | 49 | 98 | 35 | 35 | 70 |
Female | 38 | 36 | 74 | 13 | 12 | 25 |
Age | ||||||
(Ave.) | 60.9 | 60.2 | 60.6 | 59.3 | 60.5 | 59.9 |
PS | ||||||
0 | 66 | 66 | 132 | 36 | 35 | 71 |
1 | 19 | 19 | 38 | 12 | 10 | 22 |
2 | 2 | 0 | 2 | 0 | 2 | 2 |
pT | ||||||
1 | 41 | 45 | 86 | 12 | 13 | 25 |
2 | 46 | 40 | 86 | 24 | 24 | 48 |
3 | 12 | 10 | 22 | |||
pN | ||||||
0 | 6 | 1 | 7 | |||
1 | 18 | 19 | 37 | |||
2 | 24 | 27 | 51 | |||
Stage | ||||||
I | 87 | 85 | 172 | |||
II | 16 | 17 | 33 | |||
IIIA | 32 | 30 | 62 | |||
Histology | ||||||
Adenocarcinoma | 67 | 68 | 135 | 29 | 27 | 56 |
Squamous cell carcinoma | 17 | 15 | 32 | 17 | 17 | 34 |
Large cell carcinoma | 3 | 2 | 5 | 2 | 3 | 5 |
DNA pattern | ||||||
Diploidy | 18 | 17 | 35 | 10 | 8 | 18 |
Aneuploidy | 69 | 68 | 137 | 38 | 39 | 77 |
Abbreviations: PS, performance status; pT, pathological tumour stage; pN, pathological lymph node stage.